×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Bishop Hans Edgar

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AAGILENT TECHNOLOGIES, INC.Bishop Hans EdgarDirectorMar 16, 2023Option Exercise$136.822,399328,23122,379Mar 20, 2023, 09:38 PM
LYELLyell Immunopharma, Inc.Bishop Hans EdgarDirectorSep 08, 2022Option Exercise$0.10145,38014,5384,685,614Sep 09, 2022, 04:05 PM
AAGILENT TECHNOLOGIES, INC.Bishop Hans EdgarDirectorMar 17, 2022Option Exercise$136.822,582353,26919,853Mar 21, 2022, 05:03 PM
LYELLyell Immunopharma, Inc.Bishop Hans EdgarDirectorFeb 23, 2022Option Exercise$0.10993,42899,3434,540,234Feb 25, 2022, 04:05 PM
AAGILENT TECHNOLOGIES, INC.Bishop Hans EdgarDirectorMar 18, 2021Option Exercise$121.592,672324,89717,176Mar 22, 2021, 03:14 PM
AAGILENT TECHNOLOGIES, INC.Bishop Hans EdgarDirectorAug 03, 2020Option Exercise$93.9117716,62214,456Aug 05, 2020, 06:30 PM
AAGILENT TECHNOLOGIES, INC.Bishop Hans EdgarDirectorApr 17, 2020Option Exercise$73.014,108299,92114,228Apr 21, 2020, 07:32 PM
AAGILENT TECHNOLOGIES INCBishop Hans EdgarDirectorMar 21, 2019Option Exercise$82.003,450282,90010,032Mar 22, 2019, 02:20 PM
AAGILENT TECHNOLOGIES INCBishop Hans EdgarDirectorMar 22, 2018Option Exercise$67.474,314291,0666,522Mar 23, 2018, 06:27 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentMar 05, 2018Option Exercise$87.002,312,777201,211,599184,281Mar 07, 2018, 06:15 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentFeb 07, 2018Option Exercise$85.494,346371,5402,564,509Feb 09, 2018, 07:29 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentJan 16, 2018Sale$27.21516,00014,041,4982,772,679Jan 18, 2018, 09:30 PM
AAGILENT TECHNOLOGIES INCBishop Hans EdgarDirectorJul 18, 2017Option Exercise$61.212,199134,6012,199Jul 18, 2017, 06:29 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentSep 27, 2016Sale$19.6888,0001,731,8402,490,859Sep 29, 2016, 06:02 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentSep 19, 2016Option Exercise$18.1885615,5622,518,537Sep 21, 2016, 07:34 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentSep 20, 2016Option Exercise$18.1812,600229,0712,524,409Sep 21, 2016, 07:34 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentSep 21, 2016Option Exercise$28.5683,3642,381,1102,524,166Sep 21, 2016, 07:34 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentSep 08, 2016Option Exercise$18.2146,084839,1252,541,151Sep 09, 2016, 08:07 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentAug 31, 2016Option Exercise$22.9860,8461,398,1342,560,782Sep 02, 2016, 08:37 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentJun 30, 2016Sale$29.58159,2504,710,9562,657,859Sep 02, 2016, 08:36 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentJun 30, 2016Option Exercise$29.58159,2504,710,9562,657,859Jul 01, 2016, 08:36 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO & PresidentJun 09, 2016Sale$31.47144,7504,555,7842,704,609Jun 13, 2016, 07:21 AM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarSee RemarksFeb 29, 2016Sale$24.51144,7503,548,4452,741,359Mar 02, 2016, 09:02 PM
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO and PresidentDec 15, 2015Sale$31.11145,5004,526,8512,778,859Dec 17, 2015, 07:00 PM
DNDNDENDREON CORPBishop Hans EdgarChief Operating OfficerJul 29, 2011Option Exercise$37.652,29186,256151,189Aug 02, 2011, 06:01 PM
DNDNDENDREON CORPBishop Hans EdgarChief Operating OfficerApr 29, 2011Option Exercise$42.272,34298,998153,480May 03, 2011, 07:30 PM
DNDNDENDREON CORPBishop Hans EdgarChief Operating OfficerFeb 10, 2011Option Exercise$35.019,229323,107158,459Feb 11, 2011, 05:44 PM